Search

everythinglearnresearchcommunity

for

Search:↓

Using the drugs AMD3100 and Tacrolimus together greatly improves skin healing and hair growth after a deep skin cut by increasing stem cells in the wound.

Blocking interferon-gamma helps prevent and treat hair loss in Alopecia Areata.

Tofacitinib may be an effective and safe treatment for adolescent alopecia areata.

Dithranol reduces inflammation in alopecia areata by lowering certain immune responses.

ILC1-like cells can cause alopecia areata by disrupting hair follicle immunity, suggesting a new treatment approach.

Entospletinib effectively prevents eye and skin GVHD in mice.

Ustekinumab successfully treated a man's resistant skin condition when other treatments failed.

Basal cell carcinomas may use IDO to protect themselves from the immune system.

Janus kinase inhibitors show promise in treating autoimmune skin diseases.

Lenalidomide helps hair follicle stem cells turn into melanocytes, which may improve repigmentation in vitiligo.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

Using old drugs for new uses can help treat rare immune deficiencies.

Inactive stem cells in hair follicles and muscles can avoid detection by the immune system.

IL-17 plays a key role in severe hair loss in chronic alopecia areata.

Mycophenolate mofetil is effective for treating severe lupus nephritis in children.

Exosomes show promise as effective treatments for autoimmune skin diseases with fewer side effects.

IL-18 signaling helps mature Tregs move into the thymus.

Patient-derived stem cell melanocytes could be a promising treatment for vitiligo.

Targeting mTOR in myeloid cells may help reduce psoriasis symptoms.

Cyclosporine A treatment caused rare hair repigmentation in a 65-year-old man.

Alopecia areata is linked to reduced T cell function and auto-immunity.

New treatments for lupus show promise, but more research is needed, especially for children.

Early treatment with the right dose of stem cells can reduce lupus symptoms.

Belatacept may be a promising treatment for alopecia areata.

PI3Kδ inhibition may effectively treat cutaneous chronic graft-versus-host disease.

Early treatment of superficial fungal infections in immunocompromised patients is crucial.

Janus kinase inhibitors are promising drugs for treating autoimmune and inflammatory diseases.

Mycophenolate mofetil is safer and more effective than cyclophosphamide for treating lupus nephritis.